Syros Pharmaceuticals

Syros is a biopharmaceutical company applying a pioneering approach to discover and develop medicines that control the expression of genes with the aim of treating cancer and other serious diseases. The company has built a proprietary platform that enables it to systematically identify key genes that become dysregulated in diseased cells. The company believes that its platform will allow it to create a pipeline of gene control medicines that will provide a benefit for currently underserved patients.